MoneyWorks4Me

Aurobindo Pharma informs about press release

26 Apr 2025 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by CuraTeQ Biologics s.r.o, a wholly owned stepdown subsidiary of the Company in connection with the receipt of Positive Opinion from CHMP for Dazublys®, a Trastuzumab Biosimilar.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..